Importin 9 anticorps (AA 827-1041)

N° du produit ABIN6142507

Détail du produit anti-Importin 9 anticorps

Antigène: Importin 9 (IPO9)

Épitope: AA 827-1041

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Importin 9 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Séquence: LPGPTGKPAL EFVMAEWTSR QHLFYGQYEG KVSSVALCKL LQHGINADDK RLQDIRVKGE EIYSMDEGIR TRSKSAKNPE RWTNIPLLVK ILKLIINELS NVMEANAARQ ATPAEWSQDD SNDMWEDQEE EEEEEEDGLA GQLLSDILAT SKYEEDYYED DEEDDPDALK DPLYQIDLQA YLTDFLCQFA QQPCYIMFSG HLNDNERRVL QTIGI

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 827-1041 of human IPO9 (NP_060555.2).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000,IF,1:50 - 1:100

Commentaires:

HIGH QUALITY

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur Importin 9

Antigène: Importin 9 (IPO9)

Autre désignation: IPO9 (IPO9 Produits)

Synonymes: anticorps Imp9, anticorps 0710008K06Rik, anticorps AI845704, anticorps C78347, anticorps Ranbp9, anticorps mKIAA1192, anticorps zgc:66429, anticorps wu:fc23d12, anticorps MGC81741, anticorps IPO9, anticorps DDBDRAFT_0205722, anticorps DDBDRAFT_0229883, anticorps DDB_0205722, anticorps DDB_0229883, anticorps RGD1561940, anticorps RanBPM, anticorps RanBP9, anticorps bpm-l, anticorps bpm90, anticorps ranbp9, anticorps ranbp9-a, anticorps ranbp9-b, anticorps ranbp9b, anticorps cb457, anticorps zgc:158650, anticorps importin 9, anticorps importin 9 L homeolog, anticorps RAN binding protein 9, anticorps RAN binding protein 9 L homeolog, anticorps IPO9, anticorps Ipo9, anticorps ipo9, anticorps ipo9.L, anticorps cnrP, anticorps Ranbp9, anticorps ranbp9.L, anticorps RANBP9, anticorps ranbp9

Sujet: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates the nuclear import of RPS7, RPL18A, RPL6, histone H2A, histone H2B and histone. Prevents the cytoplasmic aggregation of RPS7 and RPL18A by shielding exposed basic domains. Mediates the nuclear import of actin (By similarity.,IPO9,Imp9,IPO9

Poids moléculaire: 115 kDa

ID gène: 55705

UniProt: Q96P70

Pathways: Protein targeting to Nucleus